Cargando…
Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation
PURPOSE: To assess the feasibility and diagnostic accuracy of multispectral MRI (MSI) in the detection and localization of biopsy markers during MRI-guided breast biopsy. METHODS: This prospective study included 20 patients undergoing MR-guided breast biopsy. In 10 patients (Group 1), MSI was acquir...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020905/ https://www.ncbi.nlm.nih.gov/pubmed/33828972 http://dx.doi.org/10.3389/fonc.2021.605014 |
_version_ | 1783674647247585280 |
---|---|
author | Eskreis-Winkler, Sarah Simon, Katherine Reichman, Melissa Spincemaille, Pascal Nguyen, Thanh D. Christos, Paul J. Drotman, Michele Prince, Martin R. Pinker, Katja Sutton, Elizabeth J. Morris, Elizabeth A. Wang, Yi |
author_facet | Eskreis-Winkler, Sarah Simon, Katherine Reichman, Melissa Spincemaille, Pascal Nguyen, Thanh D. Christos, Paul J. Drotman, Michele Prince, Martin R. Pinker, Katja Sutton, Elizabeth J. Morris, Elizabeth A. Wang, Yi |
author_sort | Eskreis-Winkler, Sarah |
collection | PubMed |
description | PURPOSE: To assess the feasibility and diagnostic accuracy of multispectral MRI (MSI) in the detection and localization of biopsy markers during MRI-guided breast biopsy. METHODS: This prospective study included 20 patients undergoing MR-guided breast biopsy. In 10 patients (Group 1), MSI was acquired following tissue sampling and biopsy marker deployment. In the other 10 patients (Group 2), MSI was acquired following tissue sampling but before biopsy marker deployment (to simulate deployment failure). All patients received post-procedure mammograms. Group 1 and Group 2 designations, in combination with the post-procedure mammogram, served as the reference standard. The diagnostic performance of MSI for biopsy marker identification was independently evaluated by two readers using two-spectral-bin MR and one-spectral-bin MR. The κ statistic was used to assess inter-rater agreement for biopsy marker identification. RESULTS: The sensitivity, specificity, and accuracy of biopsy marker detection for readers 1 and 2 using 2-bin MSI were 90.0% (9/10) and 90.0% (9/10), 100.0% (10/10) and 100.0% (10/10), 95.0% (19/20) and 95.0% (19/20); and using 1-bin MSI were 70.0% (7/10) and 80.0% (8/10), 100.0% (8/8) and 100.0% (10/10), 85.0% (17/20) and 90.0% (18/20). Positive predictive value was 100% for both readers for all numbers of bins. Inter-rater agreement was excellent: κ was 1.0 for 2-bin MSI and 0.81 for 1-bin MSI. CONCLUSION: MSI is a feasible, diagnostically accurate technique for identifying metallic biopsy markers during MRI-guided breast biopsy and may eliminate the need for a post-procedure mammogram. |
format | Online Article Text |
id | pubmed-8020905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80209052021-04-06 Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation Eskreis-Winkler, Sarah Simon, Katherine Reichman, Melissa Spincemaille, Pascal Nguyen, Thanh D. Christos, Paul J. Drotman, Michele Prince, Martin R. Pinker, Katja Sutton, Elizabeth J. Morris, Elizabeth A. Wang, Yi Front Oncol Oncology PURPOSE: To assess the feasibility and diagnostic accuracy of multispectral MRI (MSI) in the detection and localization of biopsy markers during MRI-guided breast biopsy. METHODS: This prospective study included 20 patients undergoing MR-guided breast biopsy. In 10 patients (Group 1), MSI was acquired following tissue sampling and biopsy marker deployment. In the other 10 patients (Group 2), MSI was acquired following tissue sampling but before biopsy marker deployment (to simulate deployment failure). All patients received post-procedure mammograms. Group 1 and Group 2 designations, in combination with the post-procedure mammogram, served as the reference standard. The diagnostic performance of MSI for biopsy marker identification was independently evaluated by two readers using two-spectral-bin MR and one-spectral-bin MR. The κ statistic was used to assess inter-rater agreement for biopsy marker identification. RESULTS: The sensitivity, specificity, and accuracy of biopsy marker detection for readers 1 and 2 using 2-bin MSI were 90.0% (9/10) and 90.0% (9/10), 100.0% (10/10) and 100.0% (10/10), 95.0% (19/20) and 95.0% (19/20); and using 1-bin MSI were 70.0% (7/10) and 80.0% (8/10), 100.0% (8/8) and 100.0% (10/10), 85.0% (17/20) and 90.0% (18/20). Positive predictive value was 100% for both readers for all numbers of bins. Inter-rater agreement was excellent: κ was 1.0 for 2-bin MSI and 0.81 for 1-bin MSI. CONCLUSION: MSI is a feasible, diagnostically accurate technique for identifying metallic biopsy markers during MRI-guided breast biopsy and may eliminate the need for a post-procedure mammogram. Frontiers Media S.A. 2021-03-22 /pmc/articles/PMC8020905/ /pubmed/33828972 http://dx.doi.org/10.3389/fonc.2021.605014 Text en Copyright © 2021 Eskreis-Winkler, Simon, Reichman, Spincemaille, Nguyen, Christos, Drotman, Prince, Pinker, Sutton, Morris and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Eskreis-Winkler, Sarah Simon, Katherine Reichman, Melissa Spincemaille, Pascal Nguyen, Thanh D. Christos, Paul J. Drotman, Michele Prince, Martin R. Pinker, Katja Sutton, Elizabeth J. Morris, Elizabeth A. Wang, Yi Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation |
title | Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation |
title_full | Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation |
title_fullStr | Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation |
title_full_unstemmed | Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation |
title_short | Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation |
title_sort | multispectral imaging for metallic biopsy marker detection during mri-guided breast biopsy: a feasibility study for clinical translation |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020905/ https://www.ncbi.nlm.nih.gov/pubmed/33828972 http://dx.doi.org/10.3389/fonc.2021.605014 |
work_keys_str_mv | AT eskreiswinklersarah multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT simonkatherine multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT reichmanmelissa multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT spincemaillepascal multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT nguyenthanhd multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT christospaulj multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT drotmanmichele multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT princemartinr multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT pinkerkatja multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT suttonelizabethj multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT morriselizabetha multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation AT wangyi multispectralimagingformetallicbiopsymarkerdetectionduringmriguidedbreastbiopsyafeasibilitystudyforclinicaltranslation |